Alterations in peripheral CD4+ T cell subsets and their association with metabolic markers in obese children

Reiko Saito1, Jun Hirakawa1, Mami Kuwamura1

  • 1Department of Pediatrics, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.

PubMed

Insights

Childhood obesity alters T cell populations, with lower CD4+ T cells and higher regulatory T cells observed. These immune changes in obese children differ from adults and depend on obesity duration.

Area of Science:

  • Immunology
  • Pediatrics
  • Metabolic Disorders

Background:

  • Childhood obesity is linked to chronic inflammation and immune dysregulation, potentially increasing adult obesity risk.
  • Research on the immune system in obese children is limited, necessitating further investigation.
  • Understanding immune alterations in pediatric obesity is crucial for long-term health outcomes.

Purpose of the Study:

  • To investigate peripheral blood lymphocyte subpopulations in obese children.
  • To examine the association between these lymphocyte subpopulations and metabolic markers.
  • To compare immune profiles in obese children with non-obese controls.

Main Methods:

  • Prospective study design involving 30 obese children and 22 age-matched non-obese controls.
  • Comparison of peripheral blood lymphocyte populations between obese and non-obese groups.
  • Assessment of factors influencing lymphocyte subpopulations within the obese cohort.

Main Results:

  • Obese children showed significantly lower proportions of CD4+ T cells and lower naïve to memory CD4+ T cell ratios compared to controls.
  • Regulatory T (Treg) cell counts were significantly higher in obese children.
  • Treg cell proportions correlated negatively with insulin and positively with blood glucose levels.

Conclusions:

  • Childhood obesity significantly impacts immune dysregulation, specifically affecting T cell subpopulations.
  • Observed T cell changes in obese children differ from those in obese adults.
  • The duration of obesity influences the observed immune alterations in children.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
246
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
166